IDXG Kronos AI forecast
A 30-trading-day price forecast for Interpace Biosciences Inc. (IDXG) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Interpace Biosciences Inc. at $3.93 on 2026-12-08, −28.5% from the last close of $5.50 on 2026-10-27. Eight out of ten sampled paths end between $1.47 and $5.15, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of IDXG
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $5.85 | $5.55 | $6.16 |
| 2026-11-10 | $5.96 | $5.37 | $6.18 |
| 2026-11-17 | $5.81 | $5.32 | $5.99 |
| 2026-11-24 | $5.39 | $4.96 | $5.98 |
| 2026-12-01 | $4.72 | $2.11 | $6.08 |
| 2026-12-08 | $3.93 | $1.47 | $5.15 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for IDXG?
- Kronos AI's median forecast for IDXG is $3.93 in 30 trading days, −28.5% from the last close, with a 10–90% range of $1.47 to $5.15.
- Is the IDXG Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.